[DowJonesToday]Dow Jones Slumps as Financials Lead Broad Market Retreat
The Dow Jones Industrial Average (^DJI) was down 715.91 (-1.44%) points today, reaching 48,910.06, while Dow Futures (YM=F) was down […]
Citi Nears Banamex Stake Sale; DeepSeek AI Launch Pressures Nasdaq
Key Takeaways Citigroup (C) is in advanced talks to sell additional stakes in its Mexican retail unit, Banamex, to Blackstone
Market Retreats as New 15% Global Tariffs Spark Trade Uncertainty; Nvidia Earnings Loom
U.S. equity markets are experiencing a volatile start to the week this Monday, February 23rd, 2026, as investors grapple with
PayPal Surges on Takeover Interest; Chevron Enters Exclusive Iraq Oil Talks
Key Takeaways PayPal (PYPL) shares hit session highs following reports that the payments giant is attracting takeover interest after a
[DowJonesToday]Dow Jones Plummets as Hawkish Fed Signals and Economic Data Trigger Risk-Off Sentiment
The Dow Jones Index (^DJI) was down 784.29 (-1.58%) points today, landing at 48,841.68, while Dow Futures (YM=F) was down
EU Sanctions Stalemate and Nvidia AI Expansion Drive Market Sentiment; Gold Surges Past $5,200
Key Takeaways Gold prices surged nearly 2% to a record $5,204.60/oz, reflecting heightened global instability and a flight to safety
EU-US Trade Deal Suspended as Tariff Turmoil Hits Global Markets; Dow Jones Falls 1%
Key Takeaways European Parliament suspends the EU-US trade deal ratification following a US Supreme Court ruling on tariffs, injecting fresh
Trade Chaos Intensifies: EU Freezes US Deal as Trump Retaliates Against Supreme Court Ruling
Key Takeaways The European Union has frozen the ratification of its landmark trade deal with the U.S. following a U.S.
Markets Navigate Tariff Turmoil and Geopolitical Tensions as Nvidia Earnings Loom
The U.S. stock market opened with a cautious tone on Monday, February 23, 2026, as investors grappled with a rapidly
Eli Lilly Gains FDA Approval for Zepbound KwikPen as ASML Targets 50% Efficiency Boost; Middle East Tensions Escalate
Key Takeaways Eli Lilly (LLY) received FDA approval for its Zepbound KwikPen, a four-dose device offering a full month of